China to Reform Oversight of Drug Prices, GMP Compliance

International Pharmaceutical Regulatory Monitor
A A
China’s State Council is ordering the China Food and Drug Administration, and other agencies, to implement stricter policies to reform the country’s regulation of drug prices, GMP compliance and pharmaceutical marketing.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor